SHA:603520 Market Cap

SHA:603520 has a market cap or net worth of 4.36 billion as of March 10, 2026. Its market cap has increased by 15.58% in one year.

Market Cap

4.36B

Enterprise Value

6.72B

Revenue

2.39B

Ranking

n/a

PE Ratio

n/a

Stock Price

9.94

Market Cap Chart

Since March 9, 2016, SHA:603520's market cap has increased from 2.10B to 4.36B, an increase of 107.51%. That is a compound annual growth rate of 7.57%.

Market Cap History

Date	Market Cap	% Change
Mar 10, 2026	4.36B	5.74%
Dec 31, 2025	4.12B	8.17%
Dec 31, 2024	3.81B	-21.00%
Dec 29, 2023	4.82B	-27.95%
Dec 30, 2022	6.69B	-57.86%
Dec 31, 2021	15.89B	-1.32%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sinotherapeutics	4.44B
Wuhan Hiteck Biological Pharma Co.,Ltd	4.46B
Shanghai Xiao Fang Pharmaceutical	4.49B
Tibet AIM Pharm.	4.16B
Tianjin Tianyao Pharmaceuticals	4.58B
Jinhe Biotechnology CO., LTD.	4.58B
Qianjiang Yongan Pharmaceutical	4.13B
Yabao Pharmaceutical Group	4.60B

Market Cap Rankings